BIOREM Inc. BIRMF
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 66.29% | 50.77% | 82.62% | -25.14% | 27.76% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 66.29% | 50.77% | 82.62% | -25.14% | 27.76% |
| Cost of Revenue | 56.57% | 56.76% | 43.12% | -18.81% | 20.59% |
| Gross Profit | 92.54% | 31.24% | 273.45% | -37.57% | 52.18% |
| SG&A Expenses | 45.21% | 22.46% | 64.63% | -24.22% | 29.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -100.00% | -- |
| Total Operating Expenses | 55.14% | 48.98% | 47.63% | -19.41% | 22.00% |
| Operating Income | 154.55% | 164.64% | 843.44% | -47.65% | 103.87% |
| Income Before Tax | 165.95% | 463.35% | 1,445.97% | -47.71% | 116.75% |
| Income Tax Expenses | 165.95% | 454.84% | 1,084.76% | -47.71% | 116.87% |
| Earnings from Continuing Operations | 165.95% | 466.80% | 1,591.64% | -47.71% | 116.79% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 165.95% | 466.80% | 1,591.64% | -47.71% | 116.79% |
| EBIT | 154.55% | 164.64% | 843.44% | -47.65% | 103.87% |
| EBITDA | 139.24% | 39.07% | 722.78% | -46.58% | 96.35% |
| EPS Basic | 162.80% | 468.75% | 1,679.49% | -48.38% | 112.66% |
| Normalized Basic EPS | 162.59% | 450.00% | 1,535.29% | -48.44% | 111.85% |
| EPS Diluted | 162.63% | 471.43% | 3,015.00% | -47.98% | 118.94% |
| Normalized Diluted EPS | 163.01% | 466.67% | 1,635.09% | -47.61% | 115.79% |
| Average Basic Shares Outstanding | 1.10% | -0.02% | -5.02% | 1.31% | 2.12% |
| Average Diluted Shares Outstanding | 1.05% | -1.50% | -11.63% | -0.06% | 0.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |